← Back to UNCY

Unicycive Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 12/08/2026Mar 2026Filed 12/08/2026Sep 2025Filed 12/11/2025Jun 2025Filed 12/08/2026Mar 2025Filed 12/08/2026Sep 2024Filed 12/11/2025Jun 2024Filed 12/11/2025Mar 2024Filed 12/11/2025
−$1.7−$13−$6−$6.4$0.6−$4.1$9.9−$21
−$0.06−$0.54−$0.33−$0.52−$0.50−$0.46−$1.50−$0.61
27241812128.99.435

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.